FDA Reverses Course

This past Monday, June 15, 2020, The Food and Drug Administration revoked an emergency approval for the use of the malaria drug hydroxychloroquine as a Covid-19 treatment stating that it is “unlikely to be effective in treating Covid-19,” warning against “serious side effects.” The withdrawal is because specific and conclusive research has shown that the…

Read More